DVA

达维塔保健
NYSE

实时行情|Nasdaq Last Sale

84.09
-0.56
-0.66%
盘后: 84.13 +0.04 +0.04% 16:30 02/21 EST
开盘
84.23
昨收
84.65
最高
84.46
最低
83.47
成交量
75.54万
成交额
--
52周最高
90.15
52周最低
43.40
市值
105.82亿
市盈率(TTM)
17.79
分时
5日
1月
3月
1年
5年

分析师评级

12位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测DVA价格均价为85.60,最高价位105.00,最低价为68.00。

EPS

DVA 新闻

更多
  • Warren Buffett has investing lieutenants who buy stocks for him. Here's what they are betting on
  • CNBC.com · 1天前
  • FMC sees U.S. government easing home dialysis goals
  • Reuters · 2天前
  • DaVita Names Kenny Gardner Chief People Officer
  • PR Newswire · 2天前
  • Zacks.com featured highlights include: Tempur Sealy International, Twin River Worldwide, Rite Aid, DaVita and United Therapeutics
  • Zacks · 3天前

所属板块

医疗设施与服务
-0.53%
医疗保健提供商与服务
-0.43%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

DVA 简况

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
展开

微牛提供Davita Inc(NYSE-DVA)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的DVA股票新闻,以帮助您做出投资决策。